PER
Click for more information
2.86% 6.8¢ percheron therapeutics limited

Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial, page-3

  1. arjay
    3,558 Posts.
    lightbulb Created with Sketch. 771
    clock Created with Sketch.
    26/05/21
    10:18
    Post #: 53419784
    Sounds nice. I went through the presentation again last night and in looking forward news , this was second in line after the FDA..

    Well, we know what is next...FDA minutes in the next 2 days..

    Well, we all have been waiting for other indications and in the preso, he has mentioned it in this Quater and hence I am not expecting this any time soon..maybe June..

    Good luck all ..boxes been ticked..
    ANP Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
CKA Deal with Petrosea opens the door for Cokal's ramp-up plans in Indonesia
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
GML Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.8¢ 		Change
-0.002(2.86%) 		Mkt cap ! $61.30M
Open High Low Value Volume
7.0¢ 7.0¢ 6.8¢ $17.82K 261.0K

Buyers (Bids)

No. Vol. Price($)
2 58555 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 54042 2
View Market Depth
Last trade - 12.53pm 05/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.